HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

KO 202125

a COX-2 inhibitor with antineoplastic activity; structure in first source
Also Known As:
KO-202125; KO202125
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kong, Gu: 2 articles (03/2011 - 01/2010)
2. Cho, Sung-Dae: 2 articles (03/2011 - 01/2010)
3. Park, Ji-Hye: 1 article (03/2011)
4. Oh, Miyun: 1 article (03/2011)
5. Min, Young Ki: 1 article (03/2011)
6. Oian, Tingting: 1 article (03/2011)
7. Kim, Hyun-Jun: 1 article (03/2011)
8. Lee, Jeong-Yeon: 1 article (03/2011)
9. Oh, Seung-Hyun: 1 article (03/2011)
10. Shin, Dong-Hui: 1 article (03/2011)

Related Diseases

1. Squamous Cell Carcinoma (Epidermoid Carcinoma)
2. Neoplasms (Cancer)
3. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. sauristolactam
2. Cyclooxygenase 2 (Cyclooxygenase-2)
3. Epidermal Growth Factor Receptor (EGF Receptor)
4. Estrogens (Estrogen)
5. gefitinib (Iressa)